Table 5 Development of the different groups at baseline (No work absentism, less than 5 days,...) one year after start of treatment with glatiramer acetate using the same categories (No work absentism, less than 5 days,...).
Baseline | No work absentism | ≤ 5 days absent | 6–10 days absent | 11–20 days absent | > 20 days absent | Not in employment | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
After 12 Months | N | % | N | % | N | % | N | % | N | % | N | % |
No work absentism | 59 | 21.3% | 15 | 5.4% | 20 | 7.2% | 23 | 8.3% | 22 | 7.9% | 9 | 3.3% |
≤ 5 days absent | 6 | 2.2% | 8 | 2.9% | 8 | 2.9% | 1 | 0.4% | 4 | 1.4% | 0 | 0% |
6–10 days absent | 4 | 1.4% | 1 | 0.4% | 3 | 1.1% | 2 | 0.7% | 4 | 1.4% | 0 | 0% |
11–20 days absent | 2 | 0.7% | 2 | 0.7% | 1 | 0.4% | 2 | 0.7% | 1 | 0.4% | 0 | 0% |
> 20 days absent | 0 | 0% | 0 | 0% | 3 | 1.1% | 1 | 0.4% | 13 | 4.7% | 1 | 0.4% |
Not in employment | 3 | 1.1% | 0 | 0% | 2 | 0.7% | 1 | 0.4% | 4 | 1.4% | 52 | 18.8% |